International Conference on Pharmacy and Personalized Medicine
IC2PM
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track focuses on the integration of pharmacogenomics into clinical practice, exploring how genetic variations influence drug response. Discussions will highlight recent research findings and their implications for personalized medicine.
SDG 3
SDG 4
This session will examine cutting-edge approaches in drug therapy, emphasizing novel therapeutic agents and treatment regimens. Participants will discuss the impact of these innovations on patient outcomes and healthcare systems.
SDG 3
SDG 9
This track addresses the evolving role of clinical pharmacists in patient care, focusing on medication management and therapeutic optimization. Presentations will showcase best practices and case studies from diverse healthcare settings.
SDG 3
SDG 4
This session will explore the latest advancements in pharmaceutical sciences, including drug formulation, delivery systems, and regulatory considerations. Attendees will gain insights into the challenges and opportunities in drug development.
SDG 9
SDG 12
This track will delve into innovative therapeutic strategies for managing chronic diseases, highlighting personalized approaches to treatment. Discussions will include the role of pharmacists in optimizing therapy for complex patient populations.
SDG 3
SDG 4
This session will focus on drug safety, including pharmacovigilance and risk management strategies. Participants will discuss the importance of monitoring adverse drug reactions and ensuring patient safety in pharmaceutical care.
SDG 3
SDG 16
This track will examine innovative practices in pharmacy that enhance patient care and healthcare delivery. Topics will include technology integration, telepharmacy, and collaborative practice models.
SDG 3
SDG 9
This session will address effective medication management strategies to improve patient adherence and therapeutic outcomes. Participants will share experiences and tools that facilitate comprehensive medication reviews.
SDG 3
SDG 4
This track will focus on research methodologies in pharmaceutical sciences, emphasizing both qualitative and quantitative approaches. Presentations will cover innovative research designs and their applications in drug development.
SDG 9
SDG 17
This session will explore patient-centered care models in pharmacy practice, emphasizing the importance of patient engagement in medication therapy management. Discussions will highlight strategies for improving communication and collaboration with patients.
SDG 3
SDG 4
This track will examine the future of personalized medicine, focusing on emerging trends and technologies that shape the field. Participants will discuss the implications of these advancements for pharmacy practice and patient care.
SDG 3
SDG 9